Home » Topics » BioWorld Science

BioWorld Science
RSS

New hypocholesterolemic agent from Schering-Plough

Oct. 11, 1996

Second Hedgehog-based research collaboration for Ontogeny

Oct. 11, 1996

New use for Uriach's rupatadine

Oct. 11, 1996

Gene therapy reduces the side effects of chemotherapy

Oct. 11, 1996

New strategy for reducing doxorubicin toxicity

Oct. 11, 1996

First photodynamic therapy approved in the U.S.

Oct. 11, 1996

Clinical trial program for anticancer HER-2/neu inhibitor

Oct. 11, 1996

SuperGen acquires rights to Warner-Lambert anticancer drug

Oct. 11, 1996

Kanebo reports antitumor agent with a novel mechanism of action

Oct. 11, 1996

Japanese researchers report new antimetastatic agents

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...